Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$5.17 - $16.99 $278,471 - $915,132
53,863 Added 17.04%
370,000 $3.94 Million
Q1 2022

May 13, 2022

SELL
$7.6 - $11.02 $67,358 - $97,670
-8,863 Reduced 2.73%
316,137 $2.4 Million
Q1 2021

May 14, 2021

BUY
$17.58 - $32.59 $1.49 Million - $2.77 Million
85,000 Added 35.42%
325,000 $7.82 Million
Q4 2020

Jan 19, 2021

BUY
$10.99 - $20.4 $549,500 - $1.02 Million
50,000 Added 26.32%
240,000 $4.32 Million
Q2 2020

Jul 16, 2020

SELL
$9.57 - $24.37 $575,846 - $1.47 Million
-60,172 Reduced 24.05%
190,000 $4.61 Million
Q1 2020

Apr 16, 2020

SELL
$9.07 - $26.32 $119,977 - $348,160
-13,228 Reduced 5.02%
250,172 $2.76 Million
Q4 2019

Jan 17, 2020

SELL
$20.54 - $31.0 $5.59 Million - $8.44 Million
-272,257 Reduced 50.83%
263,400 $6.96 Million
Q3 2019

Oct 16, 2019

BUY
$22.78 - $40.58 $5.95 Million - $10.6 Million
261,383 Added 95.3%
535,657 $12.2 Million
Q2 2019

Jul 22, 2019

BUY
$16.03 - $31.1 $995,543 - $1.93 Million
62,105 Added 29.27%
274,274 $8.41 Million
Q1 2019

Apr 11, 2019

BUY
$14.4 - $21.45 $566,625 - $844,036
39,349 Added 22.77%
212,169 $3.52 Million
Q4 2018

Feb 05, 2019

BUY
$16.51 - $51.33 $2.85 Million - $8.87 Million
172,820 New
172,820 $3.31 Million

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.